A detailed history of Sherbrooke Park Advisers LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 98,579 shares of MDXG stock, worth $914,813. This represents 0.13% of its overall portfolio holdings.

Number of Shares
98,579
Previous 77,577 27.07%
Holding current value
$914,813
Previous $538 Million 8.37%
% of portfolio
0.13%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.65 - $7.76 $118,661 - $162,975
21,002 Added 27.07%
98,579 $583 Million
Q2 2024

Aug 14, 2024

BUY
$6.16 - $8.08 $138,353 - $181,476
22,460 Added 40.75%
77,577 $538 Million
Q1 2024

May 15, 2024

BUY
$7.61 - $8.63 $419,440 - $475,659
55,117 New
55,117 $424 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.